<--- Back to Details
First PageDocument Content
Pharmaceuticals policy / Clinical pharmacology / Drugs / Pharmacy / Patient safety / European Medicines Agency / Prescription drug / Pharmacovigilance / Adverse effect / Medical prescription / Pharmaceutical industry in China / Pharmaceutical industry
Pharmaceuticals policy
Clinical pharmacology
Drugs
Pharmacy
Patient safety
European Medicines Agency
Prescription drug
Pharmacovigilance
Adverse effect
Medical prescription
Pharmaceutical industry in China
Pharmaceutical industry

SELF-CARE AGENDA 2020 ESTABLISH EVIDENCEBASED POLICIES ENHANCE

Add to Reading List

Source URL: www.aesgp.eu

Download Document from Source Website

File Size: 2,22 MB

Share Document on Facebook

Similar Documents

Web-Scale Pharmacovigilance: Listening to Signals from the Crowd Ryen W. White Ph.D.1*, Nicholas P. Tatonetti Ph.D.2, Nigam H. Shah M.B.B.S. Ph.D.3, Russ B. Altman M.D. Ph.D.4 and Eric Horvitz M.D. Ph.D.1 1 Microsoft Re

DocID: 1vpEW - View Document

Centre Anti Poison et de Pharmacovigilance du Maroc Société Marocaine de Toxicologie

DocID: 1v4Ie - View Document

Microsoft Word - Simple guide to Veterinary Pharmacovigilance in the EU

DocID: 1uY7F - View Document

PREPARATION D’UN DIPLOME DE TOXICOLOGIE - PHARMACOVIGILANCE   

DocID: 1uOXD - View Document

Liste des inscrits à la formation de toxicologie pharmacovigilance Année 2005 – 2006 Module « Pharmacovigilance » Nom Abouali Fatima Achour Sanaa

DocID: 1uKFW - View Document